Clinical Trials Logo

Immune Tolerance clinical trials

View clinical trials related to Immune Tolerance.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05192720 Completed - Allergic Asthma Clinical Trials

Andosan in Allergic and Asthma Patients

Start date: August 31, 2021
Phase: N/A
Study type: Interventional

Examine whether daily oral ingestion of a immunomodulatory mushroom extract (AndoSanTM) in patients with asthma and allergy, undergoing allergen specific immunotherapy experience clinical and biochemical improvement in their disease. A prospective randomised study comparing the mushroom extract with placebo.

NCT ID: NCT04525456 Completed - Viral Infection Clinical Trials

Immune Responses With Reduxium

Start date: October 7, 2020
Phase: N/A
Study type: Interventional

Reduxium is a dietary supplement that provides immune support. This natural compound is orally-ingested in the form of droplets in water to boost the immune system and control inflammation. There is not enough data on the mechanism associated with the action of Reduxium or the extent of the immune response increase it produces. In this study, the investigators propose treating a group of healthy volunteers with Reduxium and investigate the utility of this approach in boosting the native and adaptive immune responses that correlate with immune protection. This may form the basis for a future study employing the product in infectious disease patients.

NCT ID: NCT04038827 Completed - Clinical trials for Endothelial Dysfunction

Origin of CEC in Patients After Allo-HSCT

DCEC-PIANO
Start date: August 27, 2019
Phase:
Study type: Observational

We believe that CEC, besides coming from cells shedding from patient vasculature, could partly belong to donor, originating from the cellular graft.

NCT ID: NCT03393793 Completed - Heart Failure Clinical Trials

HEart trAnsplantation Registry of piTie-Salpetriere University Hospital

HEARTS
Start date: January 1, 2009
Phase:
Study type: Observational

Heart transplantation (HTx) is a procedure which is hindered by several complications. The HEARTS registry aims to allow the analysis of risk factors of all post-HTx complications. It consists in an exhaustive data collection at the moment of inclusion, i.e. HTx, knowing that patients underwent a full-fledged evaluation beforehand to evaluate their aptitude to being transplanted. Post-HTx complications include but is not limited to: all-cause mortality, AMR, ACR, CAV, AKI, sepsis, cancer, psychological disorders, metabolic disorders.

NCT ID: NCT03383211 Completed - HIV Infections Clinical Trials

Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers

IMMUNEO
Start date: June 16, 2017
Phase:
Study type: Observational

Maternal infections affect the basal immune status of neonates. One of the possible mechanism is the fetomaternal microchimerism, in which some cells and active substances are exchanged bi-directionally between maternal and fetal circulation through placenta. Even in the absence of a direct (vertical) transmission of pathogens to fetuses, certain infections make the neonates more prone to allergies and some adverse events of early vaccinations. We postulate that the basal immune status of neonates born to HIV and LTBI infected mothers is primed by gestational exposure to immunological active molecules, which could results in an altered response to early BCG vaccination. Transcripts expression identified by RNA sequencing are compared between sets of mother-child and their respective umbilical cord blood, and between groups of infected and non-infected pairs.

NCT ID: NCT03103113 Completed - Infertility, Female Clinical Trials

The Evolution of Relationship Between Results of Peripheral Blood Test and Outcomes of in Vitro Fertilization

Start date: April 30, 2012
Phase: N/A
Study type: Observational

The purpose of this study was to assess the relationship between infertility blood test results and outcomes of pregnancy and alive birth of women who underwent with or without intravenous immunoglobulin (IVIG) before in vitro fertilization.

NCT ID: NCT02642237 Completed - Immune Tolerance Clinical Trials

The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response

LPS-Fluenz
Start date: December 2015
Phase: N/A
Study type: Interventional

To evaluate the bacterial-viral interactions between LPS and Fluenz as a model for sepsis (bacterial) and Influenza (viral) infections which are common and associated with high mortality rates in the ICU. To understand these interactions is important for the development of preventive and therapeutic interventions.

NCT ID: NCT02541916 Completed - Immunosuppression Clinical Trials

Liver Immune Tolerance Marker Utilization Study

LITMUS
Start date: April 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to validate and test a tolerance gene expression profile for the identification of operationally tolerant liver transplant recipients, allowing for the successful withdrawal of immunosuppression without rejection in these patients.

NCT ID: NCT02255604 Completed - Allergy Clinical Trials

Effect of Intralymphatic Immunotherapy

Start date: August 2013
Phase: Phase 2
Study type: Interventional

The investigators want to investigate whether specific immunotherapy can be delivered directly into a lymph node. The investigators think that a direct introduction of allergen to the antigen presenting cells in the lymph node a give a strong immune response and that this can change the number of injections needed in allergen immunotherapy. The investigators do measurements of clinical effect and a variety of paraclinical test to see if the investigators can find af biomarker of successful specific immune therapy of grass allergy.

NCT ID: NCT01996774 Completed - Immune Tolerance Clinical Trials

Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance

TOY
Start date: February 2012
Phase: N/A
Study type: Observational

Many authors propose the strict avoidance of allergenic food as the only treatment for children known to be allergic to certain food. However, it has been observed an increase of the frequency and severity of the allergic accidents in these children in the long term. Other teams have suggested treating these allergies (in particular peanut allergies) by controlled and progressive reintroduction of the allergenic food. A good tolerance and a prevention of allergic reactions consecutive to the ingestion of the same allergenic food were observed. The immunological mechanisms of this type of treatment are not well known. A decrease of specific IgE and an increase of IgG4 have been observed in the case of egg allergies after this kind of treatment. Certain experiments realized in mice models testing the allergenic stimulation challenge showed an increase of lymphocytes T regulators (foxp3+ , CD4+, CD25+), stimulated by dendritic cells, and also an increase of interleukin 10, leading to the modification of the balance between Th1 and Th2.Our hypothesis is that after treating allergies by the reintroduction of the allergenic food, the immunological mechanism of acquisition of tolerance is associated to variations in populations of lymphocytes and in the activation or decrease of pro and anti-inflammatory cytokines. This reaction will be studied in two groups: 1. Children with a confirmed allergy to peanuts or nuts and 2. Children without antecedents of allergy or familiar atopy.